SCHEMBL18562452

SCHEMBL18562452

CC(F)(F)[C@](C)(O)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
TSHR P16473 3/20 0.50
HMGCR P04035 1/20 0.35
CHRM1 P11229 1/20 0.35
TBXA2R P21731 1/20 0.35
ADRA1A P35348 1/20 0.35
PDK1 Q15118 3/20 0.34
PDK2 Q15119 3/20 0.34
PDK3 Q15120 3/20 0.34
PDK4 Q16654 3/20 0.34
ACLY P53396 2/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
HIF1A Q16665 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TET2 Q6N021 2/20 0.32
THRB P10828 1/20 0.32
TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL569205 0.84 ALDH1A1 (0.53) ALDH1A1TSHRHMGCRCHRM1TBXA2R
SCHEMBL568925 0.84 ALDH1A1 (0.53) ALDH1A1TSHRHMGCRCHRM1TBXA2R
SCHEMBL568924 0.84 ALDH1A1 (0.53) ALDH1A1TSHRHMGCRCHRM1TBXA2R
SCHEMBL10453248 0.79 ALDH1A1 (0.64) ALDH1A1TSHRHMGCRCHRM1TBXA2R
SCHEMBL606619 0.79 ALDH1A1 (0.64) ALDH1A1TSHRHMGCRCHRM1TBXA2R
SCHEMBL10472538 0.79 ALDH1A1 (0.64) ALDH1A1TSHRHMGCRCHRM1TBXA2R
SCHEMBL26348105 0.77 THRB (0.46) ALDH1A1TSHRHMGCRCHRM1TBXA2R
SCHEMBL26348120 0.76
SCHEMBL1953736 0.73 TSHR (0.56) ALDH1A1TSHRHMGCRCHRM1TBXA2R
SCHEMBL1953738 0.73 TSHR (0.56) ALDH1A1TSHRHMGCRCHRM1TBXA2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170057943-A1 HYDROXYTRIAZINE COMPOUNDS AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC. (JP) 2017-03-02 US disclosed
US-20170057943-A1 HYDROXYTRIAZINE COMPOUNDS AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC. (JP) 2017-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170057943-A1 HYDROXYTRIAZINE COMPOUNDS AND PHARMACEUTICAL USE THEREOF PTGS1, PTGIS, PTGES ALDH1A1 618/4885TSHR 3622/4885HMGCR 275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.